Operational EfficiencyImproved EBIT margin indicates enhanced operational efficiency, suggesting the company is effectively managing its costs and operations, which can support long-term profitability.

Equity PositionA strong equity ratio highlights robust capitalization, providing financial stability and flexibility to invest in growth opportunities, enhancing long-term resilience.

Revenue GrowthSteady revenue growth reflects the company's ability to expand its market presence and product offerings, supporting sustained business expansion over time.

Bears Say

Cash Flow ChallengesNegative free cash flow indicates inefficiencies in converting profits into cash, which can limit the company's ability to fund operations and growth initiatives.

Declining Net Profit MarginA declining net profit margin suggests increasing pressure on profitability, which could affect the company's ability to generate returns for shareholders in the long term.

Return On EquityA decrease in return on equity indicates challenges in generating returns from equity investments, which could impact investor confidence and capital raising capabilities.

Kopran Limited News

Kopran Closes Trading Window Ahead of Q3 Results Under SEBI Norms

Kopran Limited ( ($IN:KOPRAN) ) has provided an update. Kopran Limited has announced that its trading window for...

2M ago

Kopran Limited Announces Board Changes

Kopran Limited ( ($IN:KOPRAN) ) has shared an announcement. Kopran Limited has announced changes in its Board of...

5M ago

KOPRAN FAQ

What was Kopran Limited’s price range in the past 12 months?

Kopran Limited lowest stock price was ₹119.60 and its highest was ₹214.65 in the past 12 months.

What is Kopran Limited’s market cap?

Kopran Limited’s market cap is ₹6.43B.

When is Kopran Limited’s upcoming earnings report date?

Kopran Limited’s upcoming earnings report date is May 21, 2026 which is in 87 days.

How were Kopran Limited’s earnings last quarter?

Kopran Limited released its earnings results on Jan 22, 2026. The company reported ₹1.934 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.934.

Is Kopran Limited overvalued?

According to Wall Street analysts Kopran Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kopran Limited pay dividends?

Kopran Limited pays a Annually dividend of ₹3 which represents an annual dividend yield of 1.96%. See more information on Kopran Limited dividends here

What is Kopran Limited’s EPS estimate?

Kopran Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kopran Limited have?

Kopran Limited has 48,285,606 shares outstanding.

What happened to Kopran Limited’s price movement after its last earnings report?

Kopran Limited reported an EPS of ₹1.934 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.111%.

Which hedge fund is a major shareholder of Kopran Limited?

Currently, no hedge funds are holding shares in IN:KOPRAN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.